U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo


CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

ProAmatine (Midodrine Hydrochloride) Tablets
Company:  Shire Laboratories Inc.
Application No.:  19-815/S5
Approval Date: 3/20/2002


leftarrow.gif (1098 bytes) Back to Drug Approval Page

Some documents are in Portable Document Format (PDF) to retain the original format. To view or print these documents, you must use the Adobe Acrobat viewer. Acrobat is free and available directly from Adobe's website with full installation instructions. Get Adobe Acrobat

FDA/Center for Drug Evaluation and Research
Last Updated: May 14, 2002
Originator: OTCOM/DLIS
HTML by Ej

Methopyrone - <engine id="OnTitle"/> " /> " />